Marcio Souza - Jan 10, 2025 Form 4 Insider Report for Praxis Precision Medicines, Inc. (PRAX)

Role: Chief Executive Officer, Director
Signature: /s/ Alex Nemiroff, as Attorney-in-Fact
Stock symbol: PRAX
Transactions as of: Jan 10, 2025
Transactions value $: $0
Form type: 4
Date filed: 1/14/2025, 06:50 PM
Previous filing: Jan 8, 2025
Next filing: Feb 14, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PRAX	Common Stock	Award	$0	+37.5K	+227.83%	$0.00	54K	Jan 10, 2025	Direct	F1
holding	PRAX	Common Stock						3K	Jan 10, 2025	Held by spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PRAX	Stock Option (Right to Buy)	Award	$0	+75K		$0.00	75K	Jan 10, 2025	Common Stock	75K	$63.15	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Mr. Souza was awarded 37,500 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on the one-year anniversary of the vesting commencement date of January 10, 2025. The restricted stock units may be settled only by delivering shares of the Issuer's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
F2	The shares underlying this stock option vest over a four-year period, with 25% vesting on January 10, 2026 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date.

Content

Mr. Souza was awarded 37,500 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on the one-year anniversary of the vesting commencement date of January 10, 2025. The restricted stock units may be settled only by delivering shares of the Issuer's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

The shares underlying this stock option vest over a four-year period, with 25% vesting on January 10, 2026 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date.